An Effective Prophylactic and Therapeutic Protection Against Botulinum Type A Intoxication in Mice and Rabbits Using a Humanized Monoclonal Antibody

An Effective Prophylactic and Therapeutic Protection Against Botulinum Type A Intoxication in Mice and Rabbits Using a Humanized Monoclonal Antibody

Botulinum neurotoxins (BoNTs) are the most potent toxins on Earth and are classified as Category A biological agents. BoNTs lead to paralysis in humans and cause botulism. Antibody therapeutics can effectively treat toxin-mediated infectious diseases. In this study, we generated a pharmaceutical hum...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chi Ho Yu, Young-Jo Song, Dong Hyun Song, Hae Eun Joe, Chang-Hwan Kim, Hyungseok Yun, Na Young Kim, Euni Sim, Seong Tae Jeong, Gyeung Haeng Hur
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Series:	Toxins
Subjects:	botulinum neurotoxin monoclonal antibody mouse rabbit
Online Access:	https://www.mdpi.com/2072-6651/17/3/138
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Production of monoclonal antibodies against botulinum neurotoxin in Nicotiana benthamiana
by: Kornchanok Sangprasat, et al.
Published: (2024-12-01)

New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A
by: Marina Vladimirovna Silkina, et al.
Published: (2024-07-01)

Overview of botulinum neurotoxin-producing clostridia in soils in France
by: Caroline Le Maréchal, et al.
Published: (2025-08-01)

Applications, impacts and consequences of botulinum toxin usage in medicine
by: Weronika Kiełt, et al.
Published: (2024-10-01)

Single Tri-Epitopic Antibodies (TeAbs) to Botulinum Neurotoxin Serotypes B, E, and F Recapitulate the Full Potency of a Combination of Three Monoclonal Antibodies in Toxin Neutralization
by: Jianlong Lou, et al.
Published: (2025-06-01)

Design and evaluation of mRNA encoding recombinant neutralizing antibodies for botulinum neurotoxin type B intoxication prophylaxis
by: Gulisaina Qiaerxie, et al.
Published: (2024-12-01)

Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip
by: Domenico Azarnia Tehran, et al.
Published: (2018-05-01)

The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: a Systematic Literature Review
by: Anton Rubis, et al.
Published: (2020-06-01)

The Emerging Role of Botulinum Neurotoxin in Psoriasis Management: A Review of Mechanisms, Evidence, and Challenges
by: Ramadan S. Hussein
Published: (2025-03-01)

Botulism outbreak in cattle due to ingestion of accidental deteriorated feed
by: Milena Carolina Paz, et al.
Published: (2024-12-01)

Pathogenicity and virulence of Clostridium botulinum
by: Alexander M. Rawson, et al.
Published: (2023-12-01)

International Proficiency Test Targeting a Large Panel of Botulinum Neurotoxin Sero- and Subtypes in Different Matrices
by: Christine Rasetti-Escargueil, et al.
Published: (2024-11-01)

Hemimasticatory spasm. Own experience of using botulinum neuroprotein type A
by: A. N. Korenko, et al.
Published: (2022-04-01)

Do Diagnostic Nerve Blocks Affect the Starting Dose of Botulinum Neurotoxin Type A for Spasticity? A Case-Control Study
by: Mirko Filippetti, et al.
Published: (2024-09-01)

Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure
by: Richard L. Barbano, et al.
Published: (2025-03-01)

Simultaneous occurrence of type C botulism in poultry and dogs
by: Andressa S. Martins, et al.
Published: (2025-07-01)

Development of a Recombinant Fusion Vaccine Candidate Against Lethal <i>Clostridium botulinum</i> Neurotoxin Types A and B
by: Eun-Sun Choi, et al.
Published: (2025-01-01)

Botulinum Neurotoxin A-Induced Muscle Morphology Changes in Children with Cerebral Palsy: A One-Year Follow-Up Study
by: Charlotte Lambrechts, et al.
Published: (2025-06-01)

Histopathological changes of the buccal mucosa and skin after botulinum neurotoxin intramuscular injection in rats (immunohistochemical study)
by: Gihan S. Hassan, et al.
Published: (2025-02-01)

Do female and male patients with cervical dystonia respond differently to long-term botulinum neurotoxin therapy?
by: Harald Hefter, et al.
Published: (2025-06-01)

Combined treatment with antitoxin and 3,4-diaminopyridine improves survival outcomes after lethal botulinum neurotoxin challenge
by: Sean W. O’Brien, et al.
Published: (2025-07-01)

Striatal Toe: Too Harmless to Treat?
by: Wolfgang H. Jost, et al.
Published: (2025-04-01)

Economic Evaluation of the InTENSE Program of Therapy Alongside Botulinum Neurotoxin a for the Rehabilitation of Chronic Upper Limb Spasticity
by: Rachel Milte, et al.
Published: (2025-07-01)

Computational Immunogenetic Analysis of Botulinum Toxin A Immunogenicity and HLA Gene Haplotypes: New Insights
by: Eqram Rahman, et al.
Published: (2025-04-01)

Effects of Combined Vibration Ergometry and Botulinum Toxin on Gait Improvement in Asymmetric Lower Limb Spasticity: A Pilot Study
by: Harald Hefter, et al.
Published: (2025-01-01)

Recombinant expression of receptor binding domains of all eight subtypes of botulinum neurotoxin type A for generation of antitoxins with broad reactivity [version 1; peer review: 1 approved, 2 approved with reservations]
by: Anh Thi Phuong Tran, et al.
Published: (2025-02-01)

A nerve clamp electrode design for indirect stimulation of skeletal muscle
by: Corey J. Hilmas, et al.
Published: (2010-10-01)

Intramuscular Botulinum Neurotoxin Injections for Infantile Esotropia: A Durban Academic Hospital Review
by: Mohammed Khan, et al.
Published: (2025-02-01)

Generation of Novel Monoclonal Antibodies Recognizing Rabbit CD34 Antigen
by: Jaromír Vašíček, et al.
Published: (2025-07-01)

Case Report: Combination of focal vibration therapy and botulinum toxin injections to treat equinus gait in a child with unilateral spastic cerebral palsy
by: Christophe Boulay, et al.
Published: (2025-02-01)

The Relationship Between Stiff Knee Gait Runner’s Dystonia and Musculoskeletal Knee Pathology: A Case Series
by: Jared A. Stowers, et al.
Published: (2025-03-01)

Efficacy and safety of valbenazine in the treatment of cervical dystonia: a pilot study
by: Salma Aziz, et al.
Published: (2025-05-01)

Botulinum toxin: yesterday, today, tomorrow
by: A. R. Artemenko, et al.
Published: (2015-02-01)

Efficacy of isolated periocular botulinum toxin A injections versus periocular and adjunctive lower facial injections in hemifacial spasm: a randomized, controlled, noninferiority, crossover trial
by: Akarawit Eiamsamarng, et al.
Published: (2025-12-01)

Foodborne Botulism Caused by <i>Clostridium botulinum</i> Subtype A5(b3) by Self-Packaged Vacuum Spicy Rabbit Heads
by: Wen Cui, et al.
Published: (2025-07-01)

Rabbits, Rabbits, Rabbits, Member Manual
by: Norman Young
Published: (1990-11-01)

Rabbits, Rabbits, Rabbits, Member Manual
by: Norman Young
Published: (1990-11-01)

Recombinant botulinum toxin as a new stage in the development of botulinum toxin therapy. Possibilities and perspectives of use in neurological practice
by: R. K. Shikhkerimov, et al.
Published: (2022-12-01)

The Effect of Micro-Focused Ultrasound Treatment on Intradermal Botulinum Toxin Type A Injection
by: Sarawin Harnchoowong, et al.
Published: (2025-03-01)

Stable Convergent Polyneuronal Innervation and Altered Synapse Elimination in <i>Orbicularis oculi</i> Muscles from Patients with Blepharospasm Responding Poorly to Recurrent Botulinum Type-A Neurotoxin Injections
by: Brigitte Girard, et al.
Published: (2024-11-01)